Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · IEX Real-Time Price · USD
47.54
+2.88 (6.45%)
At close: May 1, 2024, 4:00 PM
48.00
+0.46 (0.97%)
After-hours: May 1, 2024, 6:33 PM EDT
Soleno Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
33
Market Cap
1.59B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 607.47K | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 3.00M | - | - |
Dec 31, 2012 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Addus HomeCare | 1.06B |
U.S. Physical Therapy | 604.80M |
Veracyte | 361.05M |
ADMA Biologics | 258.22M |
Dynavax Technologies | 232.28M |
LeMaitre Vascular | 193.48M |
Ardelyx | 124.46M |
Protagonist Therapeutics | 60.00M |
SLNO News
- 1 day ago - Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome - GlobeNewsWire
- 2 days ago - Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS) - GlobeNewsWire
- 12 days ago - Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results - GlobeNewsWire
- 2 months ago - Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Soleno Therapeutics to Present at Upcoming February Investor Conferences - GlobeNewsWire
- 3 months ago - Soleno Therapeutics Strengthens Leadership Team with Key Appointments - GlobeNewsWire
- 4 months ago - The best-performing stock of the year rose nearly 10-fold, while the second-best averted disaster to surge 1,000% in a wild 2023 - Market Watch